Clinical Trial Update: A Multicenter Registry of Adalimumab in Chinese Adult Patients With Active Ankylosing Spondylitis

View source ↗

Summary

A multicenter registry evaluating adalimumab in Chinese adults with active ankylosing spondylitis; trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Spondylitis, Ankylosing | Status: UNKNOWN